BioSpace News Archive

Extended range of services supports accelerated drug discovery and development using predictive 3D Liver-on-Chip technology

Trimedic Therapeutics has submitted to Health Canada an application for the importation and sale of its COVID-19 rapid antigen test under the Interim Order pathway.

WebMD Health Corp., an Internet Brands company and a leader in health information services for physicians, other healthcare professionals and consumers, announced that it has entered into an agreement to acquire coliquio, a German-based information and education platform for healthcare professionals.

Teleflex Incorporated delivers COMPLETE confidence to central line inserters with the release of the Arrow® ErgoPack® Complete CVC System, the most important update to its market-leading1 portfolio of Centrally-Inserted Central Catheters in more than a decade.

Synlogic, Inc., a clinical stage company bringing the transformative potential of synthetic biology to medicine, announced the Company will release its third quarter 2020 financial results before the market opens on Thursday, November 5, 2020.

Revenue in the third quarter of 2020 increased 5 percent driven by volume growth of 9 percent, while on a year-to-date basis revenue increased 6 percent driven by volume growth of 12 percent.

EMD Serono, the biopharmaceutical business of Merck KGaA, Darmstadt, Germany in the US and Canada, is pleased to announce that eligible patients have access to PrMAVENCLAD® (cladribine tablets) through seven provincial public drug plans including the Régie de l’assurance maladie du Québec (RAMQ) and the Ontario Drug Benefit Exceptional Access Program.

The International Myeloma Working Group, a body of the world’s top myeloma experts established and supported by the International Myeloma Foundation, has created a new way to identify which patients with smoldering multiple myeloma are candidates for early treatment and clinical trials

LEO Pharma Inc. today announced that data from across its dermatology portfolio of approved and investigational medicines will be presented at the 29th Congress of the European Academy of Dermatology and Venereology (EADV), Vienna, Oct. 29-31, 2020. EADV’s 29th Congress will be fully virtual.

Covetrus (NASDAQ: CVET), a global leader in animal-health technology and services, announced today that it will release third quarter 2020 results after the market close on Tuesday, November 10, 2020.